These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38533029)

  • 1. Validation of a new kit for preeclampsia screening: A comprehensive analysis.
    Zhu M; Liu J; Cao J; Ni Y; Chang M; Chen R; Su Z; Yu W; Ye H
    Heliyon; 2024 Mar; 10(6):e28080. PubMed ID: 38533029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
    van Helden J; Weiskirchen R
    Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
    Stepan H; Hund M; Dilba P; Sillman J; Schlembach D
    Clin Chem Lab Med; 2019 Aug; 57(9):1339-1348. PubMed ID: 31323000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.
    Kumar N; Das V; Agarwal A; Agrawal S
    AJOG Glob Rep; 2023 May; 3(2):100177. PubMed ID: 36911235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of adverse maternal outcomes of early severe preeclampsia.
    Mirkovic L; Tulic I; Stankovic S; Soldatovic I
    Pregnancy Hypertens; 2020 Oct; 22():144-150. PubMed ID: 32979729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit.
    Miller JJ; Higgins V; Melamed N; Hladunewich M; Ma L; Yip PM; Fu L
    J Appl Lab Med; 2023 May; 8(3):457-468. PubMed ID: 36869760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria.
    Lehnen H; Mosblech N; Reineke T; Puchooa A; Menke-Möllers I; Zechner U; Gembruch U
    Geburtshilfe Frauenheilkd; 2013 May; 73(5):440-445. PubMed ID: 24771924
    [No Abstract]   [Full Text] [Related]  

  • 10. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
    Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
    PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
    Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
    Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
    Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
    Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
    Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of angiogenic factors in women with chronic kidney disease and suspected superimposed preeclampsia.
    Molina-Pérez CJ; Nolasco-Leaños AG; Carrillo-Juárez RI; Leaños-Miranda A
    J Nephrol; 2022 Jul; 35(6):1699-1708. PubMed ID: 35353367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
    Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
    J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study.
    Gao J; Huang X; Di W; Dong X; Gou W; Shi H; Wang Z; Dietl A; Grill S; Hund M
    Front Cardiovasc Med; 2021; 8():602560. PubMed ID: 34497833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia.
    Pant V; Yadav BK; Sharma J
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):266. PubMed ID: 31345176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.